Microbot up after partnering with Stryker to develop robotic procedural kits

Microbot Medical

27/12/2021 12:51

** Shares of medical devices co Microbot Medical Inc
 MBOT.O  rise ~33% to $7.23 in premarket trade — set to open at
their highest in more than one-and-a-half months 
    ** Co to partner with medical technology co Stryker Corp
 SYK.N  to integrate its neurovascular instruments with MBOT's
LIBERTY Robotic System, to develop robotic procedural kits for
use in certain neurovascular procedures  urn:newsml:reuters.com:*:nGNX3j8Lg2 
    ** Co will continue to develop the LIBERTY independently for
use in peripheral and coronary procedures
    ** Pre-clinical studies of LIBERTY showed its potential to
allow physicians to safely and efficiently conduct certain types
of remote vascular procedures, and reduce the risk for radiation
exposure, physical strain on the user and Hospital Acquired
Infections - MBOT
    ** Up to Friday's close, stock had fallen 21.34% YTD 

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))